The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,263
Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms
Dressman, J. B., Amidon, G. L., Reppas, C., & Shah, V. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011984216775 · Cited by 1,097
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
KECK, C., & MULLER, R. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.05.009 · Cited by 1,061
Muller, R. H., & Keck, C. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.06.007 · Cited by 819
Liversidge, G. G., & Cundy, K. C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00122-y · Cited by 739
The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs
KIPP, J. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.019 · Cited by 529
Jinno, J.-I., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G. G., Higaki, K., & Kimura, T. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.013 · Cited by 510
Nanosuspensions for the Formulation of Poorly Soluble Drugs
Müller, R., Jacobs, C., & Kayser, O. (2000) · Drugs and the Pharmaceutical Sciences · doi:10.1201/b14005-13 · Cited by 501
Nanosuspensions for the formulation of poorly soluble drugs
Müller, R. H., & Peters, K. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00311-6 · Cited by 480
Production and Characterization of a Budesonide Nanosuspension for Pulmonary Administration
Jacobs, C., & Müller, R. H. (2002) · Pharmaceutical Research · doi:10.1023/a:1014276917363 · Cited by 439
Mosharraf, M., & Nyström, C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00033-f · Cited by 386
Mohammed, A. R., Weston, N., Coombes, A. G. A., Fitzgerald, M., & Perrie, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.010 · Cited by 386
Micron‐Size Drug Particles: Common and Novel Micronization Techniques
Rasenack, N., & Müller, B. W. (2004) · Pharmaceutical Development and Technology · doi:10.1081/pdt-120027417 · Cited by 357
Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen
Pignatello, R., Bucolo, C., Ferrara, P., Maltese, A., Puleo, A., & Puglisi, G. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00057-x · Cited by 350
Hecq, J., Deleers, M., Fanara, D., Vranckx, H., & Amighi, K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.014 · Cited by 339
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304
Liversidge, G. G., & Conzentino, P. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00148-c · Cited by 294
Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability
Müller, R. H., & Jacobs, C. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00040-6 · Cited by 280
Liposomen: Möglichkeiten der Medikamentenfreisetzung
Allen, T. M. (1997) · Drugs · doi:10.2165/00003495-199700544-00004 · Cited by 279
Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide
Jacobs, C., Kayser, O., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00412-3 · Cited by 232
Peters, K. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.1.77 · Cited by 228
Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting
Göppert, T. M., & Müller, R. H. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.025 · Cited by 221
Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract
Ponchel, G., Montisci, M.-J., Dembri, A., Durrer, C., & Duchêne, D. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00098-2 · Cited by 191
Formulation of amphotericin B as nanosuspension for oral administration
Kayser, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00686-5 · Cited by 186
Zhang, J.-Y., Shen, Z.-G., Zhong, J., Hu, T.-T., Chen, J.-F., Ma, Z.-Q., & Yun, J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.05.048 · Cited by 165
Influence of high pressure homogenisation equipment on nanodispersions characteristics
Liedtke, S., Wissing, S. A., Müller, R. H., & Mäder, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00417-2 · Cited by 140
Liquid-phase synthesis of nanoparticles: Particle size distribution dynamics and control
Mantzaris, N. V. (2005) · Chemical Engineering Science · doi:10.1016/j.ces.2005.04.012 · Cited by 115
Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance
Hancock, B. C., Carlson, G. T., Ladipo, D. D., et al. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00133-3 · Cited by 110
Hydrosols : alternatives for the parenteral application of poorly water soluble drugs
Gassmann, P., List, M., Schweitzer, A., & Sucker, H. (1994) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 103
Douroumis, D., & Fahr, A. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.02.004 · Cited by 88
Bioadhesion of solid oral dosage forms, why and how?
Duchêne, D., & Ponchel, G. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00097-0 · Cited by 85
Kayser, O. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00640-2 · Cited by 71
Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs
Böhm, B. H. L., & Müller, R. H. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00177-7 · Cited by 67
Heavy metal contamination of nanosuspensions produced by high-pressure homogenisation
Krause, K., Kayser, O., Mäder, K., et al. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00414-7 · Cited by 62
Physical Stability of Ethyl Diatrizoate Nanocrystalline Suspension in Steam Sterilization
Na, G. C., Stevens, J., Yuan, B. O., & Rajagopalan, N. (1999) · Pharmaceutical Research · doi:10.1023/a:1018883431970 · Cited by 48
Plasma protein adsorption patterns on surfaces of Amphotericin B-containing fat emulsions
Schmidt, S. H. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00667-1 · Cited by 10
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Physical and chemical stability of drug nanoparticles
Wu, L., Zhang, J., & Watanabe, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.001 · Cited by 993
Shegokar, R., & Müller, R. H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.044 · Cited by 740
Nanonization strategies for poorly water-soluble drugs
Chen, H., Khemtong, C., Yang, X., Chang, X., & Gao, J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.02.009 · Cited by 642
High drug-loading nanomedicines: progress, current status, and prospects
Shen, S., Wu, Y., Liu, Y., & Wu, D. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s132780 · Cited by 618
Metadata
- Authors
- Gao, L., Zhang, D., & Chen, M.
- Venue
- Journal of Nanoparticle Research
- Published
- 2008-03-22
- Volume
- 10
- Issue
- 5
- Pages
- 845-862
- ISSN
- 1388-0764 (ISSN-L)
- 1572-896X
- OpenAlex
- W2047393407
- Cited by
- 420
- References
- 37
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.